Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan

Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease and end-stage kidney disease. Renin–angiotensin system inhibitors such as losartan are the predominant therapeutic options in clinical practice to treat DKD. Therefore, it is necessary to identify DKD-related metabolic prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyeon, Jin Seong, Jung, Youngae, Lee, Gayoung, Ha, Hunjoo, Hwang, Geum-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730544/
https://www.ncbi.nlm.nih.gov/pubmed/33255934
http://dx.doi.org/10.3390/ijms21238969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730544/
https://www.ncbi.nlm.nih.gov/pubmed/33255934
http://dx.doi.org/10.3390/ijms21238969

Ejemplares similares